Local recurrence of hepatocellular carcinoma after segmental transarterial chemoembolization: Risk estimates based on multiple prognostic factors

Korean Journal of Radiology

Volumn 8, Issue 2, 2007, Pages 111-119

  Seung, Hyun Park ^a   Yun, Ku Cho ^a   Ahn, Yong Sik ^a   Park, Yoon Ok ^a   Jae, Kyun Kim ^a   Jin, Wook Chung ^b  

^a Seoul Veterans Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Chemoembolization; Liver neoplasms, therapy

Indexed keywords

IODINATED POPPYSEED OIL;

ADULT; AGED; ARTICLE; CHEMOEMBOLIZATION; CHI SQUARE DISTRIBUTION; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RADIOGRAPHY; RETROSPECTIVE STUDY; RISK FACTOR; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IODIZED OIL; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34147113396     PISSN: 12296929     EISSN: None     Source Type: Journal    
DOI: 10.3348/kjr.2007.8.2.111     Document Type: Article

References (27)

1. Colella G, Bottelli R, De Carlis L, Sansalone CV, Rondinara GF, Alberti A, et al. Hepatocellular carcinoma: comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization. Transpl Int 1998;11:S193-S196
2. Segawa T, Izawa K, Tsunoda T, Kanematsu T, Shima M, Matsunaga N, et al. Evaluation of hepatectomy in small hepatocellular carcinoma - comparison with transcatheter arterial embolization therapy. Nippon Geka Gakkai Zasshi 1992;93:1095-1099
3. Nakamura H, Hashimoto T, Oi H, Sawada S. Transcatheter oil chemoembolization of hepatocellular carcinoma. Radiology 1989;170:783-786
4. Bronowicki JP, Vetter D, Dumas F, Boudjema K, Bader R, Weiss AM, et al. Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patients. Cancer 1994;74:16-24
5. Uchida H, Ohishi H, Matsuo N, Nishimine K, Ohue S, Nishimura Y, et al. Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and Gelfoam particles for hepatocellular carcinoma. Cardiovasc Interv Radiol 1990;13:140-145
6. Takayasu K, Suzuki M, Uesaka K, Muramatsu Y, Moriyama N, Yoshida T, et al. Hepatic artery embolization for inoperable hepatocellular carcinoma; prognosis and risk factors. Cancer Chemother Pharmacol 1989;23:S123-S125
7. Yamada R, Kishi K, Sonomura T, Tsuda M, Nomura S, Satoh M. Transcatheter arterial embolization in unresectable hepatoellular carcinoma. Cardiovasc Intervent Radiol 1990;13:135-139
8. Pelletier G, Roche A, Ink O, Anciaux ML, Derhy S, Rougier P, et al. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 1990;11:181-184
9. Takayasu K, Muramatsu Y, Maeda T, Iwata R, Furukawa H, Muramatsu Y, et al. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR Am J Roentgenol 2001;176:681-688
10. Maeda S, Fujiyama S, Tanaka M, Ashihara H, Hirata R, Tomita K. Survival and local recurrence rates of hepatocellular carcinoma patients treated by transarterial chemolipiodolization with and without embolization. Hepatol Res 2002;23:202-210
11. Cho YK, Chung JW, Ahn YS, Park YO, Kim JK, Byun JH. Risk factors for local tumor recurrence after segmental transarterial chemoembolization in hepatocellular carcinoma: the importance of tumor located in the segmental border zone. Korean J Radiol 2006;7:267-274
12. Nguyen MH, Garcia RT, Simpson PW, Wright TL, Keeffe EB. Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis. Hepatology 2002;36:410-417
13. Fischer L, Cardenas C, Thorn M, Benner A, Grenacher L, Vetter M, et al. Limits of Couinaud's liver segment classification: a quantitative computer-based three-dimensional analysis. J Comput Assist Tomogr 2002;26:962-967
14. Choi D, Choo SW, Lim JH, Lee SJ, Do YS, Choo IW. Opacification of the intrahepatic portal veins during CT hepatic arteriography. J Comput Assist Tomogr 2001;25:218-224
15. Hori T, Nagata K, Hasuike S, Onaga M, Motoda M, Moriuchi A, et al. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol 2003;38:977-981
16. Cho YK, Rhim H, Ahn YS, Kim MY, Lim HK. Percutaneous radiofrequency ablation therapy of hepatocellular carcinoma using multitined expandable electrodes: comparison of subcapsular and nonsubcapsular tumors. AJR Am J Roentgenol 2006;186:S269-S274
17. Poon RT, Ng KK, Lam CM, Ai V, Yuen J, Fan ST. Radiofrequency ablation for subcapsular hepatocellular carcinoma. Ann Surg Oncol 2004;11:281-289
18. Komorizono Y, Oketani M, Sako K, Yamasaki N, Shibatou T, Maeda M, et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer 2003;97:1253-1262
19. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000;214:761-768
20. Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, et al. Small hepatocelluar carcinoma in cirrhosis: Randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003;228:235-240
21. Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000;232:381-391
22. Bonny C, Abergel A, Gayard P, Chouzet S, Ugehetto S, Slim K, et al. Radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis. Gastroenterol Clin Biol 2002;26:735-741 (Article in French)
23. Chen MH, Wei Y, Yan K, Gao W, Dai Y, Huo L, et al. Treatment strategy to optimize radiofrequency ablation for liver malignancies. J Vasc Interv Radiol 2006;17:671-683
24. de Baere T, Bessoud B, Dromain C, Ducreux M, Boige V, Lassau N, et al. Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion. AJR Am J Roentgenol 2002;178:53-59
25. Yamasaki T, Kurokawa F, Shirahashi H, Kusano N, Hironaka K, Okita K. Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. Comparison with standard percutaneous radiofrequency ablation therapy. Cancer 2002;95:2353-2360
26. Rhim H, Kim YS. Intrahepatic regional portal blood flow modulation using percutaneous US-monitoring portal vein compression during radiofrequency thermal ablation. Cardiovasc Intervent Radiol 2003;26:416-418
27. Rhim H. Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow: comparison with standard percutaneous radiofrequency ablation therapy. Cancer 2003;98:433-434